FDA issues potency assurance guidance for cell and gene therapies
FDA has issued industry guidance on potency assurance for cellular and gene therapy products, signaling tighter expectations for product consistency and release testing.
By Dr. A. Nikhil Krishnan, MBBS
·
5 days ago
·
5 min read